Financials
- Market Capitalization 89.28 M
- Employee 6
- Founded 2004
- CEO Todd C. Brady M.D., Ph.D.
- Website www.aldeyra.com
- Headquarter Delaware, United States
- FIGI BBG0029H8ZF6
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-5.61
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3987 | ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.09 USD | +1.46% | -5.43% | +37.50% | +59.54% | 89.56 M USD | ||
| 3989 | ATRA Atara Biotherapeutics, Inc. - Common Stock | 8.90 USD | -3.26% | -7.00% | +5.70% | -39.66% | 89.34 M USD | ||
| 3991 | RLYB Rallybio Corporation - Common Stock | 16.79 USD | -0.12% | -0.12% | +5.20% | +3128.85% | 89.16 M USD | ||
| 3994 | ICCC ImmuCell Corporation - Common Stock | 9.79 USD | -1.51% | -0.81% | -13.59% | +55.64% | 88.91 M USD |